JavaScript is disabled for your browser. Some features of this site may not work without it.
Use of eCommons for rapid dissemination of COVID-19 research
In order to maximize the discoverability of COVID-19 research, and to conform with repository best practices and the requirements of publishers and research funders, we provide special guidance for COVID-19 submissions.
2017 CVM News: Dr. Brian VanderVen's paper pinpoints a new target for tuberculosis drugs
Other Titles
New discovery holds potential as tuberculosis drug
Abstract
The news item from the Cornell Chronicle is about: Dr. Brian VanderVen, assistant professor of microbiology and immunology, and colleagues at Cornell’s College of Veterinary Medicine, have discovered a key metabolic mechanism in Mycobacterium tuberculosis (Mtb) bacteria, which presents as a novel drug target for potentially treating tuberculosis. The finding is published in the journal eLife.
Date Issued
2017-06-27Publisher
Cornell University, College of Veterinary Medicine
Subject
Cornell University. College of Veterinary Medicine -- Periodicals.; VanderVen, Brian; Roberts, Lauren Cahoon; Cornell Chronicle
Type
article